Phosphoinositide 3-kinases in health and disease - PubMed (original) (raw)

Review

Phosphoinositide 3-kinases in health and disease

Alessandra Ghigo et al. Subcell Biochem. 2012.

Abstract

In the last decade, the availability of genetically modified animals has revealed interesting roles for phosphoinositide 3-kinases (PI3Ks) as signaling platforms orchestrating multiple cellular responses, both in health and pathology. By acting downstream distinct receptor types, PI3Ks nucleate complex signaling assemblies controlling several biological process, ranging from cell proliferation and survival to immunity, cancer, metabolism and cardiovascular control. While the involvement of these kinases in modulating immune reactions and neoplastic transformation has long been accepted, recent progress from our group and others has highlighted new and unforeseen roles of PI3Ks in controlling cardiovascular function. Hence, the view is emerging that pharmacological targeting of distinct PI3K isoforms could be successful in treating disorders such as myocardial infarction and heart failure, besides inflammatory diseases and cancer. Currently, PI3Ks represent attractive drug targets for companies interested in the development of novel and safe treatments for such diseases. Numerous hit and lead compounds are now becoming available and, for some of them, clinical trials can be envisaged in the near future. In the following sections, we will outline the impact of specific PI3K isoforms in regulating different cellular contexts, including immunity, metabolism, cancer and cardiovascular system, both in physiological and disease conditions.

PubMed Disclaimer

Cited by

[AZD9291 suppresses proliferation and migration of nasopharyngeal carcinoma cells by inhibiting the PI3K-AKT-mTOR pathway].
Zhang H, Pang J, Zhang Y, Ma Y, Fan F, Liu H. Zhang H, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2022 Sep 20;42(9):1403-1409. doi: 10.12122/j.issn.1673-4254.2022.09.18. Nan Fang Yi Ke Da Xue Xue Bao. 2022. PMID: 36210715 Free PMC article. Chinese.
Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells.
Houslay DM, Anderson KE, Chessa T, Kulkarni S, Fritsch R, Downward J, Backer JM, Stephens LR, Hawkins PT. Houslay DM, et al. Sci Signal. 2016 Aug 16;9(441):ra82. doi: 10.1126/scisignal.aae0453. Sci Signal. 2016. PMID: 27531651 Free PMC article.
An Overview of Class II Phosphoinositide 3-Kinases.
Heng EYZ, Maffucci T. Heng EYZ, et al. Curr Top Microbiol Immunol. 2022;436:51-68. doi: 10.1007/978-3-031-06566-8_2. Curr Top Microbiol Immunol. 2022. PMID: 36243839
Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.
Mannella V, Boehm K, Celik S, Ali T, Mirza AN, El Hasnaouy M, Kaffa A, Lyu Y, Kafaei Golahmadi D, Leigh IM, Bergamaschi D, Harwood CA, Maffucci T. Mannella V, et al. Int J Mol Sci. 2021 Mar 30;22(7):3567. doi: 10.3390/ijms22073567. Int J Mol Sci. 2021. PMID: 33808215 Free PMC article.
Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling.
Maffucci T, Falasca M. Maffucci T, et al. Int J Mol Sci. 2020 Sep 29;21(19):7198. doi: 10.3390/ijms21197198. Int J Mol Sci. 2020. PMID: 33003448 Free PMC article. Review.

Phosphoinositide 3-kinases in health and disease - PubMed (original) (raw)